theravance.com (TBPH) - Nilai Buku saben Saham

This price chart, serving as confirmation of the market valuation, demonstrates the price action of Theravance Biopharma (TBPH), whose respiratory product manufacturing facilities operate with high efficiency and regular equipment upgrades. The current figure is 5.61. The business relies on recognition from pulmonologists due to its high-quality inhalation products. Additionally, Theravance Biopharma (TBPH) generates revenue from partner royalties while developing therapies for infections and respiratory tracts.

Book value per share reflects the actual tangible asset base of each security. By analyzing the fair book value of a share, an investor assesses the difference between the company's total assets and liabilities. The trend of this indicator is sensitive to asset revaluations and the accumulation of retained earnings. For Theravance Biopharma (TBPH), this metric confirms financial stability during the implementation of its strategy to receive royalties from GSK. Growth in this metric indicates the effective development of its own drug portfolio.